Pharmaceutical products

Tender description

NHS National Framework Agreement for the supply of aseptically prepared cytotoxic medicines and monoclonal antibodies — North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points. NHS National Framework Agreement for the supply of aseptically prepared cytotoxic medicines and monoclonal antibodies — North of England. The framework agreement will commence on 1 April 2021 for a period of 12 months, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.